An ISO can stop dispensing in 24 hours. The hearing is months away.
Request a Free Case ReviewDEA's diversion control posture has tightened materially since 2022. Registration applications face heightened scrutiny. Routine inspections produce Orders to Show Cause. Immediate Suspension Orders can stop a pharmacy or practice from dispensing within 24 hours, and the administrative hearing on the merits is months away.
The criminal track runs in parallel through DOJ when the inspection record supports prosecution. Health Law Alliance defends DEA registrants across pharmacies, physicians, distributors, and manufacturers. In 2025, we filed a federal court action that lifted an Immediate Suspension Order against a pharmacy client, naming the DEA Administrator as defendant.
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
With upmost professional respect, I will be forever grateful to have such caring individuals as Attorney Anthony Mahajan and Attorney Diana Yastrovskaya who come into my life, even though I am a business owner but I always felt I was treated as a friend and was made reaching out to them with ease.
I had a great experience working with Health Law Alliance. From the very beginning, their team was incredibly helpful, responsive, and professional. They answered all of my questions quickly and kept me informed throughout the entire process.
Anthony and his staff have gone above and beyond. His proactive communication and ability to handle complex legal scenarios effectively have been a significant asset. Highly recommended attorney.
Top-notch attorneys with an unparalleled scope of experience and breadth of knowledge. You will want them in your corner.
Had nothing but great experience from them. Knowledgeable and professional in all aspects. They have a vast knowledge in health care cases, great to be on your side against insurances.
Trustworthy and experienced.
An Immediate Suspension Order stops dispensing today. An Order to Show Cause threatens the registration. A criminal referral threatens personal liberty. The defense posture has to address all three on different timelines.
DEA can issue an ISO on a finding that continued registration poses an "imminent danger to public health or safety." Once served, the registrant must stop dispensing controlled substances within 24 hours. The administrative hearing on the merits is typically 3 to 6 months away. Federal court action under 21 USC § 877 is the only mechanism that can lift the ISO before the hearing.
A revoked DEA registration cannot be transferred, sold, or restored without going through the full reapplication and DEA review process. For a pharmacy, registration loss ends controlled substance dispensing across the entire schedule list. For a prescriber, it ends the ability to write controlled substance prescriptions. Restoration applications face heightened scrutiny that can take 1 to 3 years to resolve.
DEA inspection findings often produce criminal referrals to DOJ. The Controlled Substances Act carries up to 20 years per count for distribution outside the course of professional practice, with mandatory minimums in some patterns. Personal liability for owners, prescribers, and pharmacists-in-charge is the rule, not the exception. The criminal track often runs in parallel with the administrative track.
DEA runs its own administrative process under its own evidentiary standards. The clock, the forum, and the rules of engagement are different from PBM audits, CMS reviews, or DOJ civil matters. Defense counsel that does not know the DEA process loses procedural ground in the first 24 hours.
What an inspection produces, and how a registrant responds to it, becomes the record DEA relies on in an Order to Show Cause, an Immediate Suspension Order, and any administrative hearing.
Our bench includes a former federal prosecutor and senior healthcare-company counsel. We have filed federal court action against the DEA Administrator to lift an Immediate Suspension Order, drafted OTSC responses for hearings before DEA Administrative Law Judges, and coordinated DEA defense with parallel DOJ criminal matters. This is the protocol.
Within 24 hours of an Immediate Suspension Order: evaluate the basis cited (controlled substance dispensing pattern, recordkeeping deficiencies, alleged diversion), reconstruct the inventory reconciliation record DEA will rely on, confirm whether federal court action under 21 USC § 877 is available, and prepare emergency filings. We have lifted an ISO through federal court action and we know what the pleading needs to say.
For Orders to Show Cause: draft and file the response within the statutory window, conduct DEA-side discovery, prepare witnesses, and present the case before the Administrative Law Judge. The ALJ proceeding has its own evidentiary standards distinct from federal court, and the record built at the ALJ stage is the record the DEA Administrator will review.
Many DEA matters resolve through negotiated outcomes before the Final Order issues: corrective action plans, memorandums of agreement, voluntary registration modifications. Direct engagement with DEA Diversion Control and the relevant U.S. Attorney's Office often produces resolution that protects the registration even where the inspection findings are partially substantiated.
When the DEA matter produces a criminal referral to DOJ: white-collar defense engagement runs in parallel with the administrative track. Pre-charge advocacy, grand jury subpoena response, target letter response, and federal court defense if charges issue. Our former-federal-prosecutor bench coordinates the criminal defense with the DEA administrative defense as one matter.
Health Law Alliance handles the response and any parallel appeal, licensing matter or referral as one coordinated matter, so the strategy does not change hands as the matter moves between forums.
The bench includes a former Assistant U.S. Attorney nominated for the DOJ Director's Award, senior healthcare-company counsel, and attorney-providers with experience across healthcare audits and investigations.
Agency and company marks identify former professional experience of individual HLA team members. They do not imply affiliation, endorsement, or a client relationship.
DEA's Diversion Control Division ranks registrants on multiple analytics metrics, then deploys field investigators to the highest-risk locations. The following patterns are the most common predicates for a routine inspection that escalates.
Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.
Immediate Suspension Order Lifted
HLA filed an emergency federal action after DEA issued an Immediate Suspension Order, resulting in dismissal of the pending enforcement action and restoration of the pharmacy’s authority to dispense controlled substances.
Indictment Dismissed
The four-count indictment, once part of a national crackdown on opioid-related misconduct, was dismissed by the court in full, with no plea deal, no fine, and no admission of guilt. All charges were dropped, including Anti-Kickback Statute violations, healthcare fraud, conspiracy to defraud the United States, and violations of the Controlled Substances Act.
Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific matter.
Seven questions that come up on almost every first call. The answers below are general; specific situations require privileged consultation.
Before DEA serves the ISO, before the OTSC hearing locks in the administrative posture, before DOJ files the criminal complaint, have a privileged conversation with attorneys who defend DEA matters across registration, inspection, ISO, OTSC, and parallel criminal exposure. Free, confidential, no retainer.